https://www.inhsu.org/publication/restrictions-for-reimbursement-of-interferon-free-direct-acting-antiviral-drugs-for-hcv-infection-in-europe/ 2021-01-14T02:12:59+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/strategies-for-achieving-universal-access-to-hepatitis-c-virus-prevention-and-care-for-people-who-inject-drugs/ 2021-01-14T02:13:25+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/expanding-access-to-prevention-care-and-treatment-for-hepatitis-c-virus-infection-among-people-who-inject-drugs/ 2021-01-14T02:14:09+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/recommendations-for-the-management-of-hepatitis-c-virus-infection-among-people-who-inject-drugs/ 2021-01-14T02:14:41+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/contradictory-advice-for-people-who-inject-drugs-in-the-2016-easl-recommendations-on-treatment-of-hepatitis-c/ 2021-01-14T02:15:06+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/excluding-people-who-use-drugs-or-alcohol-from-access-to-hepatitis-c-treatments-is-this-fair-given-the-available-data/ 2021-01-14T02:15:47+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/elimination-of-hepatitis-c-virus-infection-among-people-who-use-drugs-ensuring-equitable-access-to-prevention-treatment-and-care-for-all/ 2021-01-14T02:16:39+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/elimination-of-hepatitis-c-virus-infection-among-pwid-the-beginning-of-a-new-era-of-interferon-free-daa-therapy/ 2021-01-14T02:17:09+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/perceptions-and-self-reported-competency-related-to-testing-management-and-treatment-of-hepatitis-c-virus-infection-among-physicians-prescribing-opioid-agonist-treatment-the-c-scope-study/ 2021-01-14T02:17:56+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/perceptions-and-self-reported-competency-related-to-testing-management-and-treatment-of-hepatitis-c-virus-infection-among-physicians-prescribing-opioid-agonist-treatment-the-c-scope-study-2/ 2021-01-14T05:42:44+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/research-priorities/ 2021-09-02T05:38:58+00:00 https://www.inhsu.org/wp-content/uploads/2020/12/Publication3.png https://www.inhsu.org/publication/barriers-and-advocacy-needs-for-hepatitis-c-services-in-prisons-informing-the-prisons-hepatitis-c-advocacy-toolkit/ 2024-03-21T03:53:04+00:00 https://www.inhsu.org/publication/co-creating-and-implementing-a-novel-pre-conference-event-to-promote-equity-and-inclusivity-among-academic-researchers-and-people-who-use-drugs/ 2024-05-30T02:32:53+00:00 https://www.inhsu.org/publication/co-designing-the-inhsu-prisons-hepatitis-c-advocacy-toolkit-using-the-advocacy-strategy-framework/ 2024-12-02T00:00:48+00:00 https://www.inhsu.org/publication/addressing-policy-barriers-to-scaling-up-needle-and-syringe-programmes-a-global-call-to-action/ 2026-02-01T03:07:52+00:00